[关键词]
[摘要]
目的 探讨藤黄健骨联合洛索洛芬钠治疗膝骨关节炎的临床疗效和安全性。方法 选取2016年6月—2017年6月在河南省洛阳正骨医院诊治膝骨关节炎患者152例,随机分成对照组(76例)和治疗组(76例)两组。对照组患者口服洛索洛芬钠片,1片/次,3次/d;治疗组患者在对照组基础上口服藤黄健骨丸,1丸/次,2次/d。两组患者均连续治疗6周。观察两组患者临床疗效,同时比较治疗前后两组患者骨关节炎指数、KSS评分和15 m行走时间,血清白细胞介素-1β(IL-1β)、软骨寡聚基质蛋白(COMP)和前列腺素E2(PGE2)水平及不良反应。结果 治疗后,对照组临床有效率为86.84%,显著低于治疗组的97.37%,两组比较差异具有统计学意义(P<0.05)。治疗后,两组患者骨关节炎指数和15 m行走时间均显著下降(P<0.05),KSS评分显著升高(P<0.05),且治疗组患者骨关节炎指数、KSS评分和15 m行走时间均明显优于对照组(P<0.05)。治疗后,两组患者血清IL-1β、COMP和PGE2水平均显著下降(P<0.05),且治疗组患者血清IL-1β、COMP和PGE2水平明显低于对照组(P<0.05)。治疗期间,治疗组药物不良反应发生率为2.63%,显著低于对照组的13.16%,两组比较差异具有统计学意义(P<0.05)。结论 藤黄健骨联合洛索洛芬钠治疗膝骨关节炎疗效显著、安全性高,具有一定的临床推广应用价值。
[Key word]
[Abstract]
Objective To investigate the clinical efficacy and safety of Tenghuang Jiangu Pills combined with loxoprofen sodium in treatment of knee osteoarthritis. Methods Patients (152 cases) with knee osteoarthritis in Luoyang Orthopedic Hospital of Henan Pprovince from June 2016 to June 2017 were randomly divided into control (76 cases) and treatment (76 cases) groups. Patients in the control group were po administered with Loxoprofen Sodium Tablets, 1 tablet/time, three times daily. Patients in the treatment group were po administered with Tenghuang Jiangu Pills on the basis of the control group, 1 pill/time, twice daily. Patients in two groups were treated for 6 weeks. After treatment, the clinical efficacy was evaluated, and the osteoarthritis indexes, KSS scores, 15 m walking time, serum IL-1β, COMP and PGE2 levels, and adverse reactions in two groups before and after treatment were compared. Results After treatment, the clinical efficacy in the control group was 86.84%, which was significantly lower than 97.37% in the treatment group, and there were differences between two groups (P<0.05). After treatment, the osteoarthritis indexes and 15 m walking time in two groups were significantly decreased (P<0.05), but KSS scores were significantly increased (P<0.05), and these indicators in the treatment group were significantly better than those in the control group (P<0.05). After treatment, the IL-1β, COMP and PGE2 levels in two groups were significantly decreased (P<0.05), and the serum IL-1β, COMP and PGE2 levels in the treatment group were significantly lower than those in the control group (P<0.05). During the treatment, the adverse reactions rate in the treatment group was 2.63%, which was significantly lower than 13.16% in the control group, with significant difference between two groups (P<0.05). Conclusion Tenghuang Jiangu Pills combined with loxoprofen sodium in treatment of knee osteoarthritis has significant curative effect with less adverse reactions, which has a certain clinical application value.
[中图分类号]
[基金项目]